Biomerica, Inc. Short Interest Up 50.5 percent in October
| BMRA Stock | USD 0.34 0.04 13.33% |
About 72 percent of all Biomerica's investors are curious in acquiring. The analysis of overall sentiment of trading Biomerica stock suggests that a large number of investors are confidant at this time. The current market sentiment, together with Biomerica's historical and current headlines, can help investors time the market. In addition, many technical investors use Biomerica stock news signals to limit their universe of possible portfolio assets.
Biomerica |
Biomerica, Inc. saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 562,400 shares, a growth of 50.5 percent from the October 15th total of 373,700 shares. Based on an average daily volume of 446,300 shares, the short-interest ratio is
Read at thelincolnianonline.com
 |
Biomerica Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Biomerica can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Biomerica Fundamental Analysis
We analyze Biomerica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomerica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomerica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Biomerica is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Biomerica Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biomerica stock to make a market-neutral strategy. Peer analysis of Biomerica could also be used in its relative valuation, which is a method of valuing Biomerica by comparing valuation metrics with similar companies.
Peers
Biomerica Related Equities
| BBLG | Bone Biologics | 13.27 | ||||
| MOVE | Movano | 7.95 | ||||
| AIMD | Ainos | 6.00 | ||||
| SSKN | STRATA Skin | 5.15 | ||||
| TIVC | Tivic Health | 2.94 | ||||
| MODD | Modular Medical | 2.84 | ||||
| TNON | Tenon Medical | 1.40 | ||||
| NPCE | Neuropace | 0.09 | ||||
| SRDX | SurModics | 0.40 | ||||
| SGHT | Sight Sciences | 2.51 | ||||
| NXL | Nexalin Technology | 4.67 |
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |